Stephan Sturm

Part of Fresenius SE & Co. KGaA, Fresenius Hemocare Netherlands B.V. is a healthcare company based in Emmer-Compascuum, Netherlands. The Dutch company's corporate philosophy is "caring for life," and they specialize in providing high-quality biosimilars, infusion, transfusion, and clinical nutrition products and technologies to save lives. The private company foster an environment of mutual respect, encouragement, and teamwork. More information about their business fields and career opportunities can be found on their website.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi España SA is a private company based in Barcelona, Spain that develops and produces drugs and medical devices for critical care therapies with chronic diseases worldwide. The Spanish company offers a wide range of products, including substitution of blood volume, critical disease, diabetes mellitus, liquid management, hepatic insufficiency, digestive problems/absorption, nutritional support, pediatrics, renal insufficiency, enteral nutrition, nasogastric probe food, oral nutritional supplements, anesthetic, generic medicines/antibiotic, analgesic, oncology, and other fluid therapy infion medical irrigation devices. Fresenius Kabi is committed to putting essential medicines and technologies in the hands of people who help patients and find the best responses to the challenges they face.

Part of Fresenius SE & Co. KGaA, Fresenius Medical Care Management AG is a German company that provides innovative products, therapies, and services to create a livable future for their patients. The private company is based in Bad Homburg, Germany. The company specializes in chronic and acute kidney dialysis and therapeutic apheresis. The company was founded in 2005. The CEO is Helen Giza.

Founded in 1966, FHC (Holdings) Ltd. is a British company that functions as an investment holding company. Part of Fresenius SE & Co. KGaA, the private company is based in Runcorn, UK.

Labesfal-Laboratórios Almiro SA is a pharmaceutical company based in Santiago de Besteiros, Portugal. Part of Fresenius SE & Co. KGaA, the Portuguese company develops, produces, and markets medical drugs and devices for therapy and the care of critical and chronic patients worldwide. The private company's product portfolio includes diabetes mellitus, critical disease, fluidotherapy, hepatic insufficiency, renal insufficiency, maldigestion/malabsorption, oncology, pediatrics, replacement nutritional support, medical devices, disposable devices, drainage manipulation technology, infusion technology, nutrition, enteric nutritional supplements, parenteral nutrition, specific amino acids, lipid emulsions, volume replacement, colloids, irrigation solutions, transfusion technology, and more. The company is committed to ethics, responsibility, compliance, diversity, integrity, safety, and social responsibility. The company also prioritizes career development and employee well-being.

Part of Else Kröner-Fresenius-Stiftung, Fresenius Management SE is a German company that provides investment management services. The private company is based in Bad Homburg vor der Hoehe, Germany. The company was founded in 2010. Michael Sen has been the CEO of the company since 2021.

Part of Fresenius SE & Co. KGaA, FPS Beteiligungs AG is a German company that provides investment services. The private company is based in Oberursel, Germany.